Skip to main content
Premium Trial:

Request an Annual Quote

Genome BC Lands $25.5M in Provincial Funding

NEW YORK (GenomeWeb News) – Genome British Columbia will receive C$25 million ($25.5 million) from the province of British Columbia to fund its ongoing research programs, including studies in areas such as agriculture, forestry, human health, fisheries, bioenergy, mining, and the environment, it announced on Monday.

This funding from the Ministry of Health, will allow Genome BC to continue harnessing the power of genomics research and work toward providing solutions to current challenges faced by sectors important to B.C.

Supported by BC's Ministry of Health, the new funding will support research areas in which Genome BC already has funded ongoing projects and will allow Genome BC " to continue harnessing the power of genomics research and work toward providing solutions to current challenges faced by sectors important to" British Columbia, Genome BC said in a statement

The Ministry of Health said that Genome BC's research efforts have already returned value back to the province, stating, for example, that the honeybee industry and honeybee pollination together are worth an estimated C$200 million.

According to a Vancouver Board of Trade study, the province's investment of C$75 million between 2005 and 2010 contributed $450 million to British Columbia's gross domestic product and to contribute C$54 million in tax revenues to each of the provincial and federal governments.

“Innovation is one of the keys to ensuring an efficient healthcare system," British Columbia's Minister of Health Michael de Jong said in a statement. "With this funding, important research will be able to continue that will help deliver quality services to improve the health of British Columbian families.”

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.